<p>Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the training data set (42 SCLC patients).</p
<p>A risk score was calculated for each patient in the training cohort (n = 79) using our 9-miRNA si...
<p>Overall survival (OS) of TNBC patients of 50 yrs and younger patients due to differentially expre...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastas...
<p>Kaplan-Meier analysis of cancer-specific survival in clear cell renal cell carcinoma (ccRCC) pati...
<p>A) 92 patients in the training data set. B) 92 patients in the validation data set. C) Risk score...
<p>They are all the testing cohort patients who are stratified by the 4-miRNA signature using microa...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>The Kaplan-Meier overall survival curves of two outcome groups classified by MCPHR models using I...
<p>According to the prediction model, each patient was assigned to a low-risk or high-risk group. Si...
<p>(a) Overall survival in 145 patients with lung adenocarcinomas, (b) Overall survival in 99 Stage ...
Kaplan-Meier survival analysis for Overall Survival in early-stage and metastatic patients.</p
(A) Disease-free survival (DFS) in early-stage patients and, (B) Progression-free survival (PFS) in ...
<p>Kaplan-Meier analyses of overall survival according to miR-137 expression in (A) Training set (n ...
<p>Kaplan-Meier estimates of (a) overall survival, (b) distant progression-free survival and (c) loc...
<p>A risk score was calculated for each patient in the training cohort (n = 79) using our 9-miRNA si...
<p>Overall survival (OS) of TNBC patients of 50 yrs and younger patients due to differentially expre...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastas...
<p>Kaplan-Meier analysis of cancer-specific survival in clear cell renal cell carcinoma (ccRCC) pati...
<p>A) 92 patients in the training data set. B) 92 patients in the validation data set. C) Risk score...
<p>They are all the testing cohort patients who are stratified by the 4-miRNA signature using microa...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>The Kaplan-Meier overall survival curves of two outcome groups classified by MCPHR models using I...
<p>According to the prediction model, each patient was assigned to a low-risk or high-risk group. Si...
<p>(a) Overall survival in 145 patients with lung adenocarcinomas, (b) Overall survival in 99 Stage ...
Kaplan-Meier survival analysis for Overall Survival in early-stage and metastatic patients.</p
(A) Disease-free survival (DFS) in early-stage patients and, (B) Progression-free survival (PFS) in ...
<p>Kaplan-Meier analyses of overall survival according to miR-137 expression in (A) Training set (n ...
<p>Kaplan-Meier estimates of (a) overall survival, (b) distant progression-free survival and (c) loc...
<p>A risk score was calculated for each patient in the training cohort (n = 79) using our 9-miRNA si...
<p>Overall survival (OS) of TNBC patients of 50 yrs and younger patients due to differentially expre...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...